134 related articles for article (PubMed ID: 15694744)
1. The role of lipid management in diabetes.
Ganda OP
Cardiol Clin; 2005 May; 23(2):153-64, vi. PubMed ID: 15694744
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of ezetimibe/simvastatin 10/20 and 10/40 mg compared with atorvastatin 20 mg in patients with type 2 diabetes mellitus.
Constance C; Westphal S; Chung N; Lund M; McCrary Sisk C; Johnson-Levonas AO; Massaad R; Allen C
Diabetes Obes Metab; 2007 Jul; 9(4):575-84. PubMed ID: 17451425
[TBL] [Abstract][Full Text] [Related]
3. [The CARDS Study: cardiovascular primary prevention in diabetes patients using Atorvastin].
Griebenow R
Internist (Berl); 2005 Mar; 46(3):350-2. PubMed ID: 15696286
[No Abstract] [Full Text] [Related]
4. [Considerable LDL lowering is advantageous].
MMW Fortschr Med; 2005 Sep; 147(35-36):9. PubMed ID: 16180563
[No Abstract] [Full Text] [Related]
5. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
Stender S; Schuster H; Barter P; Watkins C; Kallend D;
Diabetes Obes Metab; 2005 Jul; 7(4):430-8. PubMed ID: 15955130
[TBL] [Abstract][Full Text] [Related]
6. [Dual cholesterol inhibition. More high risk patients achieve LDL cholesterol values below 100 mg/dl].
MMW Fortschr Med; 2008 Jun; 150(23):39. PubMed ID: 18575369
[No Abstract] [Full Text] [Related]
7. [To lessen the cardiovascular risk of the diabetic patient. Atorvastatin of use for diabetic patients without coronary disease, too].
MMW Fortschr Med; 2005 Aug; 147(33-34):51. PubMed ID: 16138641
[No Abstract] [Full Text] [Related]
8. Update on heart disease. Evidence mounts for even lower LDL.
Clark WL
Diabetes Self Manag; 2007; 24(1):29-30, 32. PubMed ID: 17283507
[No Abstract] [Full Text] [Related]
9. Familial dysbetalipoproteinemia: a potentially fatal disorder.
Bari AU; Hashim R; Rahman SB; Hussain M
J Coll Physicians Surg Pak; 2008 Aug; 18(8):506-8. PubMed ID: 18798589
[TBL] [Abstract][Full Text] [Related]
10. Diabetes and residual risk of coronary heart disease.
Nesto RW; Singh PP
Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):71. PubMed ID: 17237830
[No Abstract] [Full Text] [Related]
11. A large observational study of cardiovascular outcomes associated with atorvastatin or simvastatin therapy in diabetic patients without prior cardiovascular disease.
Foody JM; Joyce AT; Jeffers BW; Liu LZ; Benner JS
Diabetes Res Clin Pract; 2008 Oct; 82(1):e13-5. PubMed ID: 18774618
[TBL] [Abstract][Full Text] [Related]
12. Synthes Award for Resident Research in Spinal Cord & Spinal Column Injury: Statins for the treatment of neurological injury: a role beyond cholesterol lowering.
McGirt MJ; Woodworth GF; Lynch JR; Laskowitz DT
Clin Neurosurg; 2004; 51():320-8. PubMed ID: 15571161
[No Abstract] [Full Text] [Related]
13. [Lipids and diabetic macroangiopathy: role of HDL].
Fuller JH; Salter A; Mattock MB
Journ Annu Diabetol Hotel Dieu; 1982; ():203-10. PubMed ID: 7098248
[No Abstract] [Full Text] [Related]
14. Variability of lipids in patients with Type 2 diabetes taking statin treatment: implications for target setting.
Sathyapalan T; Atkin SL; Kilpatrick ES
Diabet Med; 2008 Aug; 25(8):909-15. PubMed ID: 18959603
[TBL] [Abstract][Full Text] [Related]
15. Atorvastatin or fenofibrate on post-prandial lipaemia in type 2 diabetic patients with hyperlipidaemia.
Iovine C; Lilli S; Gentile A; Patti L; Di Marino L; Cipriano P; Riccardi G; Rivellese AA
Eur J Clin Invest; 2006 Aug; 36(8):560-5. PubMed ID: 16893378
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin.
Baldassarre S; Scruel O; Deckelbaum RJ; Dupont IE; Ducobu J; Carpentier YA
Int J Cardiol; 2005 Oct; 104(3):338-45. PubMed ID: 16186066
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of lipid-lowering medications in patients treated with clozapine: a naturalistic study.
Landry P; Dimitri E; Tessier S; Légaré N
J Clin Psychopharmacol; 2008 Jun; 28(3):348-9. PubMed ID: 18480696
[No Abstract] [Full Text] [Related]
18. Cholesterol-lowering effects of rosuvastatin compared with atorvastatin in patients with type 2 diabetes -- CORALL study.
Wolffenbuttel BH; Franken AA; Vincent HH;
J Intern Med; 2005 Jun; 257(6):531-9. PubMed ID: 15910557
[TBL] [Abstract][Full Text] [Related]
19. How common is rhabdomyolysis in patients receiving lipid-lowering therapy?
Phillips PS
Nat Clin Pract Cardiovasc Med; 2005 Mar; 2(3):130-1. PubMed ID: 16265453
[No Abstract] [Full Text] [Related]
20. Atorvastatin and gemfibrozil for protease-inhibitor-related lipid abnormalities.
Henry K; Melroe H; Huebesch J; Hermundson J; Simpson J
Lancet; 1998 Sep; 352(9133):1031-2. PubMed ID: 9759748
[No Abstract] [Full Text] [Related]
[Next] [New Search]
